Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

32.53 +0.42 (+1.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Vericel Corporation - Common Stock

< Previous 1 2 3 Next >
News headline image
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces Preliminary 2025 Financial Results and Business Updates
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Third Quarter 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Second Quarter 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Third Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Second Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
From Vericel Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.